Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 110429-35-1 |
MDL number | MFCD03658863 |
Molecular weight | 374.84 |
Molecular Formula | C19H20FNO3·HCl·1/2H2O |
Product code | ICTP1977 |
PubChem Substance ID | 135727290 |
Purity/Analytical Methods | >98.0%(T)(HPLC) |
Reaxys-RN | 7471375 |
Appearance | White to Light yellow powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H302 : Harmful if swallowed H315 : Causes skin irritation H319 : Causes serious eye irritation. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P270 : Do not eat, drink or smoke when using this product P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ eye protection/ face protection P337 + P313 : If eye irritation persists: Get medical advice/ attention P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302 + P352 : IF ON SKIN: Wash with plenty of soap and water P332 + P313 : If skin irritation occurs: Get medical advice/ attention P362 : Take off contaminated clothing and wash before reuse P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Signal word | Warning |
RTECS# | TM4569320 |
---|
Chemicals by Class 5-Membered Heterocyclic Compounds [Chemical Structural Class] Dioxoles [Chemical Structural Class]
Life Science Biochemicals and Reagents Pharmaceutical Ingredients (for Research and Experimental Use) Neurotransmitter Agent Ingredients (for Research and Experimental Use) Cell Biology Cancer Research Chemopreventive Agents [Cancer Research] Phase I Enzyme Inhibitor Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Neurotransmitter Agent Ingredients (for Research and Experimental Use)